Concepedia

Author

Sara Bringhen

Azienda Ospedaliera Citta' della Salute e della Scienza di TorinoORCID

Also Known As

Bringhen Sara, S Bringhen, S. Bringhen, Sara Bringhen

222

Publications

10.4K

Citations

43

H-Index

49

Concepts

All Affiliations

Azienda Ospedaliera Citta' della Salute e della Scienza di TorinoUniversity of TurinCentro di Riferimento Oncologico della BasilicataIstituti di Ricovero e Cura a Carattere ScientificoAzienda Ospedaliero Universitaria San Giovanni Battista
SB

About

Sara Bringhen is an author at Azienda Ospedaliera Citta' della Salute e della Scienza di Torino specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

24

1.6K

2

Health Sciences

14

16

1.4K

3

Public Health

2

2

48

4

Blood Transplantation

2

2

189

5

Cellular Therapies

1

1

52

Sara Bringhen

×

68

Publications

7.7K

Citations

33

H-Index

YearCitations

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva,

Journal of Clinical Oncology

2015

2.1K

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos,

Blood

2015

739

A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma

Benedetto Bruno, Marcello Rotta, Francesca Patriarca,

New England Journal of Medicine

2007

504

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

Evangelos Terpos, Martina Kleber, Monika Engelhardt,

Haematologica

2015

391

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael,

The Lancet

2021

366

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Antonio Palumbo, Sara Bringhen, Anna Marina Liberati,

Blood

2008

357

Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

Antonio Palumbo, Patrizia Falco, Paolo Corradini,

Journal of Clinical Oncology

2007

316

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

Alessandra Larocca, Federica Cavallo, Sara Bringhen,

Blood

2011

285

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

Antonio Palumbo, Sara Bringhen, Alessandra Larocca,

Journal of Clinical Oncology

2014

210

Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients

Antonio Palumbo, Francesca Gay, Patrizia Falco,

Journal of Clinical Oncology

2010

174

Page 1